This episode features Ben Merewitz, CEO and Co-founder of Agile Devices. Ben discusses the challenges faced by interventional radiologists when navigating complex anatomy with traditional microcatheters, such as difficulties in maneuvering through tortuous vessels and achieving precise target placement. Agile Devices has developed a novel, microcatheter with active tip control, called Angler, that overcomes these limitations by allowing real-time control of the tip's shape, enabling physicians to navigate complex anatomy with greater ease and precision.

The company has received FDA clearance for the Angler and is currently conducting limited releases to gather further clinical data and demonstrate the device's effectiveness in various interventional procedures, including embolization, neurovascular interventions, and more. Ben highlights the importance of the Boston area's vibrant medical device ecosystem in the development of this innovative technology and discusses the company's future plans, including expanding into new markets and developing new applications for their deflectable technology platform. With an ‘agile’ approach, Ben’s story is sure to keep you informed and inspired.

This episode features Andrew Goldsmith, Medical Director of UltraSight, and Ramya Singh, Chief Commercial Officer. They discuss the challenges of limited access to echocardiography due to a shortage of cardiac sonographers and the resulting delays in patient care. UltraSight addresses this by developing AI-powered software that guides clinicians in acquiring high-quality echocardiograms using standard ultrasound devices. This technology enhances the accessibility of ultrasound technology by enabling a wider range of healthcare professionals to perform these critical examinations.

The company focuses on improving patient outcomes by enabling faster diagnoses, reducing wait times, and improving the efficiency of healthcare delivery. UltraSight's Go-to-Market strategy targets key areas; hospitals, clinics, and home healthcare settings, aiming to integrate their solution into existing workflows and improve patient care across various settings. The company emphasizes the importance of user-friendliness, ease of implementation, and a focus on patient safety and improved outcomes. With the company primed to make real impact, tune in so you can be informed and inspired.

This episode features Evan Ruff, CEO and Co-founder of Oxos Medical. Oxos Medical is developing innovative portable X-ray devices designed to revolutionize healthcare by bringing imaging to the point of need. Recognizing the limitations of traditional X-ray systems, which are often bulky, expensive, and require specialized infrastructure, Oxos Medical has created a compact and user-friendly device that can be easily used in various settings, from emergency departments and clinics to sports fields and even remote locations.

Evan delves into the challenges of accessing traditional X-ray technology, including limited availability, high costs, and the need for specialized personnel. We discuss how Oxos Medical's portable X-ray device addresses these challenges by improving accessibility, enhancing workflow efficiency, and empowering clinicians with greater autonomy. The conversation also explores the potential of AI integration, such as AI-powered image analysis for improved diagnostic accuracy and streamlined workflows. With a strong sales pipeline in place, the OXOS team is primed to make an impact, tune in so you can be informed and inspired.

In this episode, Spencer Jones, Founder of XO Medtech, discusses the problem with innovation silos in medical technology and the commercialization process. Spencer highlights how innovators are often afraid to share information about what they are working on, and this can stifle progression. Additionally, there is a lack of access to open networks for comprehensive practical knowledge transfer related to commercialization.

Spencer outlines how XO Medtech’s platform offers a new online community approach for educating and connecting innovators, helping provide them with the resources needed to succeed. This includes a community forum, educational content, and a range of free templates. As well as aiding knowledge transfer, an additional platform, Medtech Vendors, will help improve the process of finding the right suppliers. With community and value-driven connections at the heart of all they do, this is definitely a conversation to keep you informed and inspired.

Here are the key takeaways:

• Siloed nature of Medtech and Medtech innovation: Startup resources are often constrained by location and network which can hinder innovation.
• Limited access to specialized networking & knowledge training: Medtech innovators often have difficulty finding accessible resources and support they need to succeed.
• Importance of building a community: XO Medtech is building a community of Medtech innovators to help them connect with each other and share resources.
• Focus on actionable content: The platform provides innovators with access to practical tools and templates to help them advance their businesses.
• Standardization of processes: A new Medtech Vendors platform will help standardize the procurement process in the Medtech industry to improve efficiency.

In this episode, Swarna Shiv, CEO and founder of Unsmudgeable, delves into the challenges of smudged eyewear and how her company is revolutionizing lens technology. Unsmudgeable aims to eliminate the safety and productivity issues caused by smudged glasses, a huge problem that affects millions of people globally. Swarna shares insights into how the company started, the unique technology behind their coatings, and the journey from idea to patent-pending innovation.

Unsmudgeable's focus for 2025 is commercialization and they are actively working with lens manufacturers to apply this technology to various surfaces. Swarna explains their strategy for scaling up through equity crowdfunding and emphasizes the importance of sustainability in their product development. Tune in to be informed and inspired.

The episode discusses preventative care, specifically how virtual care can help people with chronic conditions manage their health and avoid hospitalization. David Dlesk, CEO and Co-Founder of Embrace Prevention Care, shares an overview of the challenges of preventative care in the current healthcare system and how Embrace helps patients with chronic conditions, like dementia, take action to improve their health.

Embrace uses virtual consultations with nurse practitioners to provide ongoing support and coaching to patients. This helps patients make the lifestyle changes necessary to slow the progression of their chronic conditions. The Centers for Medicare & Medicaid (CMS) has created a new program, GUIDE, to specifically target dementia patients and caregivers. Embrace is one of the select organizations chosen to provide this program.

The key takeaways from the podcast episode are:

• Preventative care is not currently well- incentivized in the healthcare system, but it is critical for managing chronic conditions.
• Virtual care can be an effective way to deliver preventative care.
• CMS has created a new program, GUIDE, to provide virtual preventative care to dementia patients and caregivers.
• Embrace is a company that is using virtual care to help people with chronic conditions manage their health and avoid hospitalization.

This episode features Ben Holmes, CEO and Co-founder of Nanochon, a medical device company focused on revolutionizing cartilage repair. The discussion highlights the significant challenges faced by patients with cartilage damage, including limited treatment options and the potential for further joint degeneration.

Nanochon is developing a groundbreaking 3D-printed implant designed to mimic the natural structure and function of cartilage. This innovative device is designed to be minimally invasive and easily implanted, offering a potential solution for patients facing cartilage damage and potentially delaying or even preventing the need for knee replacement surgery.

Ben shares insights into Nanochon's development progress, including upcoming human trials and their recent move to LaunchPort in Baltimore, a unique incubator space that provides access to state-of-the-art manufacturing facilities for medtech startups. With team expansion plans on the horizon, this story is fueled with insights, sure to leave you informed and inspired.

This episode discusses a huge unmet need in the medical device space: treatment for mixed urinary incontinence. Millions of patients, primarily women, suffer from this condition, and there is no effective treatment on the market. Current treatment options leave care gaps and patients resorting to over-the-counter products for symptom management.

Juniper Biomedical is a company that is developing a new type of treatment for mixed urinary incontinence. They are developing a unique neuromodulation micro implant that can be implanted with a minimally invasive procedure to deliver a very precise therapy. This has the potential to solve the problems of mixed incontinence, eliminate issues with inaccurate diagnosis, and importantly, provide a solution that patients are more likely to accept.

CEO and co-founder, David Constantine joins us to discuss their exciting progress, from extensive preclinical studies, to upcoming clinical trials. After a year of multiple highlights, including award winning on the stage of Medtech Innovator, the future looks bright for Juniper Biomedical. Their technology has the potential to make a real difference in the lives of millions of patients with pelvic health conditions, a story sure to leave you, informed and inspired.